Monday, January 9, 2023

Uganda set to declare end of Ebola outbreak

Uganda said on Monday it was expecting to declare an end to an Ebola virus outbreak that emerged late last year and has claimed the lives of at least 56 people.

Consumers care more about taste than gene editing for table grapes

Despite some hesitation about gene-edited foods, taste trumps everything, according to a Washington State University-led survey of U.S. consumers.

source https://www.lifetechnology.com/blogs/life-technology-science-news/consumers-care-more-about-taste-than-gene-editing-for-table-grapes

AstraZeneca buys US biotech firm CinCor

Anglo-Swedish pharmaceuticals giant AstraZeneca on Monday agreed to buy US biotech company CinCor for $1.8 billion, expanding further into the field of heart and kidney drugs.

Dead endangered whale washes up on Mississippi Gulf Coast

Scientists are examining the corpse of an endangered whale that washed up on a Mississippi Gulf Coast beach.

source https://www.lifetechnology.com/blogs/life-technology-science-news/dead-endangered-whale-washes-up-on-mississippi-gulf-coast

'Vaccination desserts' identified in northern, rural and French-speaking Ontario

New research out of the University of Waterloo has identified "vaccination deserts" in parts of northern and rural Ontario and in locations where French is predominantly spoken. These areas have little to no access to pharmacist-administered vaccination sites for COVID vaccines or the flu shot.

Group summarizes new guidelines for treating patients with diabetes and chronic kidney disease

The latest clinical practice guideline from the Kidney Disease: Improving Global Outcomes (KDIGO) organization offers advice for treating patients with diabetes and chronic kidney disease (CKD). A synopsis published in Annals of Internal Medicine focuses on the key recommendations pertinent to the following issues: comprehensive care, glycemic monitoring and targets, lifestyle interventions, antihyperglycemic therapies, and educational and integrated care approaches to management.